Here, our results demonstrate that SL4 was able to induce cell cycle arrest at the G2/M phase in breast cancer cells by activating the MAPK pathway and subsequently regulating cell cycle-associated proteins, including p21, cdc25C, cdc2, cyclin B1 and cyclin A2. This evidence concerns the gene CDC25C and breast carcinoma.